Status:
COMPLETED
Sub-regional Tumor Segmentation Based on CEUS Perfusion Characteristics: Enhancing Breast Tumor Diagnosis
Lead Sponsor:
Second Affiliated Hospital, School of Medicine, Zhejiang University
Conditions:
Breast Tumor
Eligibility:
FEMALE
18+ years
Brief Summary
The goal of this study is to investigate breast cancer's internal heterogeneity and enhance diagnostic accuracy. The investigators aim to achieve this by utilizing Contrast-Enhanced Ultrasound (CEUS) ...
Detailed Description
Breast cancer is one of the most prevalent cancers among women globally, and its increasing incidence poses a significant threat to women's health. Despite notable advances in early diagnosis and trea...
Eligibility Criteria
Inclusion
- Prospective cohort patients voluntarily sign an informed consent form.
- Patients who undergo breast contrast-enhanced ultrasound.
- Patients with breast nodules that have not received any treatment.
Exclusion
- Patients who cannot obtain pathological results due to refusal of further diagnosis or treatment.
- Patients whose breast lesions are too large to display their long axis under the ultrasound probe.
- Patients contraindicated for contrast-enhanced ultrasound.
- Historical cohort patients who cannot obtain ultrasound contrast videos of at least 45-60 seconds post contrast agent injection.
- Patients whose ultrasound contrast videos show excessive motion displacement that cannot be corrected.
Key Trial Info
Start Date :
July 1 2023
Trial Type :
OBSERVATIONAL
Allocation :
ACTUAL
End Date :
January 3 2025
Estimated Enrollment :
339 Patients enrolled
Trial Details
Trial ID
NCT06172270
Start Date
July 1 2023
End Date
January 3 2025
Last Update
January 10 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Department of Ultrasound, Second Affiliated Hospital, School of Medicine, Zhejiang University
Hangzhou, Zhejiang, China, 310000